Abstract
In the case of an inadequate prescription dosage, medical risks are much higher when nutrition is administered parenteral than erental. The Kanazawa University Hospital experienced a case of chronic renal failure that developed into severe hypophosphatemia due to a glucose overdose while administering parenteral nutrition. A retrospective fact-finding study found that at this hospital the parenteral nutrition dosages containing HICALIQ-RF® had the tendency for an insufficient dosage of amino. Furthermore, lipid emulsion had not been administered in that one case, and nutrition was mainly delivered as glucose. But energy needs differ widely for patients. The unified use of transfusions should help physicians find the suitable individual nutrition dosage without differences like that. In this sense it is meaningful that the hospital's Nutrition Support Team (NST) pharmacists, who do have the specialist knowledge, deliver accurate information regarding parenteral nutrition and prepare adequate individual dosages. Specialized nutritional therapies arranged by the NST not only results in the adequate use of transfusions, but also achieve beneficial and economically results for both the patients and hospital management.
